We are live on ! Find out more
ETTX

Entasis Therapeutics Holdings Inc.
ETTX

Delisted

ETTX was delisted on the 8th of July, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Entasis Therapeutics Holdings Inc. in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 27 → 0 (-27)

100% less capital invested

Capital invested by funds: $12.5M → $0 (-$12.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 27

Holders
–
Holders Change
-27
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
27
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GLAM
Gardner Lewis Asset Management
Pennsylvania
-$2.75M
2
BCM
Beryl Capital Management
California
-$2.49M
3
TGA
TPG GP A
Texas
-$2.25M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.11M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$866K
Name Holding Trade Value Shares
Change 		Change in
Stake
GLAM
1
Gardner Lewis Asset Management
Pennsylvania
– -$2.75M -1,249,778 Closed
BCM
2
Beryl Capital Management
California
– -$2.49M -1,131,772 Closed
TGA
3
TPG GP A
Texas
– -$2.25M -1,020,748 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$1.11M -502,622 Closed
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
– -$866K -393,563 Closed
Renaissance Technologies
6
Renaissance Technologies
New York
– -$771K -350,345 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
– -$397K -180,827 Closed
DAM
8
Deltec Asset Management
New York
– -$342K -155,614 Closed
E
9
Ergoteles
New York
– -$298K -135,323 Closed
BCM
10
Bridgeway Capital Management
Texas
– -$292K -132,600 Closed
State Street
11
State Street
Massachusetts
– -$184K -83,705 Closed
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
– -$156K -70,688 Closed
GF
13
Gabelli Funds
New York
– -$130K -59,100 Closed
DMKJ
14
David M. Knott Jr
– -$92K -41,700 Closed
GCIA
15
Gabelli & Co Investment Advisers
New York
– -$90K -40,900 Closed
BlackRock
16
BlackRock
New York
– -$75K -34,356 Closed
Jane Street
17
Jane Street
New York
– -$67K -30,262 Closed
Northern Trust
18
Northern Trust
Illinois
– -$51K -23,160 Closed
VF
19
Virtu Financial
New York
– -$44K -20,027 Closed
Charles Schwab
20
Charles Schwab
California
– -$32K -14,236 Closed
TSS
21
Two Sigma Securities
New York
– -$28K -12,635 Closed
UBS Group
22
UBS Group
Switzerland
– -$27K -12,179 Closed
TRCT
23
Tower Research Capital (TRC)
New York
– -$5K -2,426 Closed
BG
24
Bollard Group
Massachusetts
– -$3K -1,448 Closed
Wells Fargo
25
Wells Fargo
California
– -$2K -1,125 Closed
1
2

ETTX Hedge Fund Activity: Q3 2022 in Review

0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q3 2022, worth a combined $0 — down 100% from $12.5M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of ETTX and 0 opened new positions — a net loss of 27 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Gardner Lewis Asset Management, exiting entirely with an estimated $2.75M sold.

  • 0 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q3 2022, down from 27 in Q2 2022.
  • Funds reported $0 of Entasis Therapeutics Holdings Inc. stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Entasis Therapeutics Holdings Inc. positions in Q3 2022 and 27 closed out, a net change of -27 holders.
  • The largest Entasis Therapeutics Holdings Inc. seller in Q3 2022 was Gardner Lewis Asset Management, an estimated $2.75M sold.

Based on aggregated 13F filings for Q3 2022.